哌拉西林联合阿奇霉素治疗肺炎支原体性肺炎的临床疗效及安全性

打开文本图片集

Clinical Efficacyand Safety of Piperacillin Combined with Azithromycin in the Treatment ofMycoplasma Pneumoniae Pneumonia

GUO Neng，CHEN Ying

（DepartmentofPediatrics，Xiajiang CountyPeople'sHospital，Xiajiang 3314O9，Jiangxi，China）

Abstract：ObetieTinvestigatethenicalfcacyndsafetyofperaciliombindwitthominintetreatmntofoas pneumoniaepeoaetdsoingtothdommbertabletodildrenithoplasmapeonaditedi CountyPeople'sHospitalfromJanuary21toOctober023werdividedintocontrolgoupandstudygoupwith30childrenieachgoupThe controlgroupadirodyspesionddoadipeaclnndbcot basisofthealceessglals factorlevelsid fever，vomiting，abdominalpain）werecomparedbetweenthetwogroups.ResultsThetotalefectiverateofthestudygroupwas 9 6 . 6 7 % ，and the total effective rate of the control group was 7 3 . 3 3 % ，thedifference between the two groupswas statistically significant .Compared with the control group，thoodd difference were statistically significant（ P<0 . 0 5 ） .Theincidence of adverse reactions in the study group was 2 3 . 3 3 % ，and the incidence of adverse reactions in the control group was 2 0 . 0 0 % ，but there was no significant diference between the two groups （ P>0 . 0 5 ） .Conclusion Piperacillin combinedwithionsfiiiicaltiraetofoplsaeoeacanootethot of clinicalsymptoms，elievethebodysinflammatoryresponse，reducetheriskofdversereactions，andhashighsafety.

Keywords：Piperacillin；Azithromycin；Mycoplasma pneumonia；Inflammatory factor levels

支原体肺炎（mycoplasmal pneumonia）是由肺炎支原体引起的肺部急性炎症，同时可伴有咽炎、支气管炎，约占非典型病原体感染的1/3左右。（剩余5534字）